Synthesis of a fluorescently labeled (68)Ga-DOTA-TOC analog for somatostatin receptor targeting Journal Article


Authors: Ghosh, S. C.; Hernandez Vargas, S.; Rodriguez, M.; Kossatz, S.; Voss, J.; Carmon, K. S.; Reiner, T.; Schonbrunn, A.; Azhdarinia, A.
Article Title: Synthesis of a fluorescently labeled (68)Ga-DOTA-TOC analog for somatostatin receptor targeting
Abstract: Fluorescently labeled imaging agents can identify surgical margins in real-time to help achieve complete resections and minimize the likelihood of local recurrence. However, photon attenuation limits fluorescence-based imaging to superficial lesions or lesions that are a few millimeters beneath the tissue surface. Contrast agents that are dual-labeled with a radionuclide and fluorescent dye can overcome this limitation and combine quantitative, whole-body nuclear imaging with intraoperative fluorescence imaging. Using a multimodality chelation (MMC) scaffold, IRDye 800CW was conjugated to the clinically used somatostatin analog, 68Ga-DOTA-TOC, to produce the dual-labeled analog, 68Ga-MMC(IRDye 800CW)-TOC, with high yield and specific activity. In vitro pharmacological assays demonstrated retention of receptor-targeting properties for the dual-labeled compound with robust internalization that was somatostatin receptor (SSTR) 2-mediated. Biodistribution studies in mice identified the kidneys as the primary excretion route for 68Ga-MMC(IRDye 800CW)-TOC, along with clearance via the reticuloendothelial system. Higher uptake was observed in most tissues compared to 68Ga-DOTA-TOC but decreased as a function of time. The combination of excellent specificity for SSTR2-expressing cells and suitable biodistribution indicate potential application of 68Ga-MMC(IRDye 800CW)-TOC for intraoperative detection of SSTR2-expressing tumors. © 2017 American Chemical Society.
Keywords: pet; somatostatin receptor; dual labeling; nirf
Journal Title: ACS Medicinal Chemistry Letters
Volume: 8
Issue: 7
ISSN: 1948-5875
Publisher: American Chemical Society  
Date Published: 2017-07-13
Start Page: 720
End Page: 725
Language: English
DOI: 10.1021/acsmedchemlett.7b00125
PROVIDER: scopus
PMCID: PMC5512127
PUBMED: 28740605
DOI/URL:
Notes: Article -- Export Date: 2 August 2017 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Thomas Reiner
    136 Reiner
  2. Susanne   Kossatz
    40 Kossatz